Sensitive ASX Announcement

AdAlta receives approval to commence AD-214 Phase I trial

Published: 10/06/20, 08:52am (AEST)3 pages
AdAlta Limited
1AD:ASXHealthcare

Recent 1AD Announcements

Price Sensitive only